Effectiveness of erlotinib in lung adenocarcinomas with classic and alternative EGFR mutations detected by Roche 454 GS-FLX next-generation sequencing (NGS).
Gyula Ostoros
No relevant relationships to disclose
Veronika Sarosi
No relevant relationships to disclose
Laszlo Mandoky
Employment or Leadership Position - Rigel
Ferenc Pinter
Employment or Leadership Position - Key Property Solutions
Stock Ownership - KPS Diagnostics
Research Funding - Roche
Richard Schwab
Employment or Leadership Position - KPS Diagnostics
Stock Ownership - KPS Diagnostics
Research Funding - Roche
Istvan Petak
Employment or Leadership Position - KPS Diagnostics
Stock Ownership - KPS Diagnostics
Research Funding - Roche
Laszlo Urban
No relevant relationships to disclose